Canine Cancer
AKC Canine Health Foundation Canine Cancer Research
Since 1995, CHF and its donors have funded over $18.1 million in canine cancer research. These 271 research grants have helped scientists study cancer at the cellular level, providing breakthroughs that allow veterinarians to diagnose cancer earlier and treat it more effectively. CHF-funded research also has a One Health impact, extending beyond dogs with an application to human cancer diagnosis and treatment.
Canine cancer research is a major concern of dog owners and veterinary professionals. Typically, about one quarter of CHF’s grant funding concerns various types of canine cancers.
View our Cancer Research Portfolio
Resources
Canine Cancer Articles
Pilot study assesses feasibility of tissue collections and molecular profiling for personalized medicine studies August 24, 2011
Personalized medicine involves tailoring cancer treatment and prevention to the specific molecular nature of the individual and their cancer. The hope is that targeted therapies will be more effective with less risk for the patient than traditional treatments.
Using Technology to Target Tumors February 25, 2011
Dr. Nicola Mason and her colleagues at the University of Pennsylvania, with the support of the AKC Canine Health Foundation, have been trying to find new ways to use antibody fragments to target a particularly devastating type of canine tumor. They are looking for a more effective treatment for canine hemangiosarcoma.
Malignant Histiocytosis: Looking for a Cure December 1, 2010
The median survival time for malignant histiocytosis is only 2-4 months. Traditional cancer treatments such as radiation and surgery are generally ineffective in dogs with MH. There is hope for the future; however, as preliminary studies of a new form of treatment have shown some real promise.
Personalizing Cancer September 4, 2010
With a $12,000, start-up grant from the AKC Canine Health Foundation, researchers at Van Andel Research Institute soon identified regions of DNA associated with hemangiosarcoma in Clumber Spaniels. Little did they know that their project would become part of a larger effort involving academic, industry and government organizations and that it would result in a revolutionary move to provide better cancer treatment not only for dogs but for people, too.
Transitional Cell Carcinoma: Once Considered Incurable, Now Highly Treatable August 2, 2010
In many respects, Frankie was a lucky dog. Just a few years ago Frankie’s diagnosis of transitional cell carcinoma (TCC) would have been a death sentence. Fortunately for Frankie and other dogs, times are changing. The past decade has seen great progress in managing TCC.
| Items 51 - 14 of 14 | Previous |
Resources Available for Download
Webinars
Cancer Attributable to Infection?
Original air date: June 8, 2022
Speaker: Edward B. Breitschwerdt, DVM, DACVIM
May 2022 Canine Cancer Webinar Series
Available on a pay per view basis through the AKC Canine College.
Predicting Lymphoma in Dogs, Presented by Dr. Daniel Promislow
Luteinizing Hormone Receptor Activation in Lymphoma and Hemangiosarcoma, Presented by Dr. Michelle Kutzler
Toward Curative Outcomes in Canine Hemangiosarcoma, Presented by Dr. Chand Khanna
LIVE Panel Q&A Session, Presented by Drs. Promislow, Kutzler, and Khanna
A Novel Non-Surgical Option to Preserve Limbs in Canine Osteosarcoma
Original air date: May 25, 2021
Speaker: Joanne Tuohy, DVM, PhD, DACVS
Podcasts
Tracie Hotchner Pets podcast spoke with CHF Board Chairman, Dr. Charles Garvin, about CHF-funded grants studying innovative new ways to detect and treat cancer.
The Dog Cancer Answers podcast spoke with AKC Chief Veterinary Officer Dr. Jerry Klein about How to Choose a Dog Breeder. Listen for ways to increase the odds of having a healthy puppy, including the importance of AKC Canine Health Foundation funded research.
How You Can Help
Your support means more studies exploring improved diagnostics and new treatment strategies for canine cancer.
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.
